Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 7:31 pm Purchase | 2023-12-31 | 13G | Verastem, Inc. VSTM | ORBIMED ADVISORS LLC | 1,529,115 6.100% | 1,529,115 (New Position) | Filing History |
| 2024-02-14 7:28 pm Sale | 2023-12-31 | 13G | SI-BONE, Inc. SIBN | ORBIMED ADVISORS LLC | 2,144,631 5.300% | -1,056,469 (-33.00%) | Filing History |
| 2024-02-14 7:21 pm Purchase | 2023-12-31 | 13G | Scholar Rock Holding Corporation SRRK | ORBIMED ADVISORS LLC | 2,960,000 4.100% | 2,960,000 (New Position) | Filing History |
| 2024-02-14 7:11 pm Sale | 2023-12-31 | 13G | Protara Therapeutics, Inc. TARA | ORBIMED ADVISORS LLC | 0 0.000% | -671,741 (Position Closed) | Filing History |
| 2024-02-14 7:00 pm Sale | 2023-12-31 | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 4,003,967 15.200% | -8,314 (-0.21%) | Filing History |
| 2024-02-14 6:55 pm Sale | 2023-12-31 | 13G | Mersana Therapeutics, Inc. MRSN | ORBIMED ADVISORS LLC | 0 0.000% | -283,313 (Position Closed) | Filing History |
| 2024-02-14 6:51 pm Sale | 2023-12-31 | 13G | Mereo BioPharma Group plc MREO | ORBIMED ADVISORS LLC | 0 0.000% | -10,378,591 (Position Closed) | Filing History |
| 2024-02-14 6:47 pm Sale | 2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR | ORBIMED ADVISORS LLC | 192,700 2.700% | -156,812 (-44.87%) | Filing History |
| 2024-02-14 6:42 pm Purchase | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | ORBIMED ADVISORS LLC | 3,000,000 6.800% | 3,000,000 (New Position) | Filing History |
| 2024-02-14 6:36 pm Sale | 2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | ORBIMED ADVISORS LLC | 1,667,360 2.500% | -1,529,516 (-47.84%) | Filing History |
| 2024-02-14 6:30 pm Sale | 2023-12-31 | 13G | Applied Therapeutics, Inc. APLT | ORBIMED ADVISORS LLC | 0 0.000% | -7,300,921 (Position Closed) | Filing History |
| 2024-02-05 4:48 pm Unchanged | 2024-02-05 | 13D | CalciMedica, Inc. CALC | ORBIMED ADVISORS LLC | 297,380 2.900% | 0 (Unchanged) | Filing History |
| 2024-02-05 4:42 pm Purchase | 2024-01-30 | 13D | ArriVent BioPharma, Inc. Common Stock AVBP | ORBIMED ADVISORS LLC | 3,027,328 9.100% | 3,027,328 (New Position) | Filing History |
| 2024-01-29 4:55 pm Purchase | 2024-01-25 | 13D | Adicet Bio, Inc. ACET | ORBIMED ADVISORS LLC | 610,787 12.900% | 195,313 (+47.01%) | Filing History |
| 2024-01-25 4:25 pm Purchase | 2024-01-23 | 13D | Edgewise Therapeutics, Inc. EWTX | ORBIMED ADVISORS LLC | 14,756,096 17.300% | 454,545 (+3.18%) | Filing History |
| 2023-12-29 4:16 pm Sale | 2023-12-28 | 13D | Alpine Immune Sciences, Inc. ALPN | ORBIMED ADVISORS LLC | 2,680,496 4.600% | -1,546,347 (-36.58%) | Filing History |
| 2023-12-27 4:43 pm Unchanged | 2023-12-22 | 13D | Theseus Pharmaceuticals, Inc. THRX | ORBIMED ADVISORS LLC | 17,713,600 40.100% | 0 (Unchanged) | Filing History |
| 2023-12-15 4:48 pm Sale | 2023-12-13 | 13D | Disc Medicine, Inc. IRON | ORBIMED ADVISORS LLC | 1,702,237 7.100% | -567,400 (-25.00%) | Filing History |
| 2023-12-13 5:20 pm Unchanged | 2023-12-11 | 13D | Keros Therapeutics, Inc. KROS | ORBIMED ADVISORS LLC | 1,268,734 4.200% | 0 (Unchanged) | Filing History |
| 2023-12-06 4:43 pm Sale | 2023-12-04 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 3,567,159 4.900% | -611,429 (-14.63%) | Filing History |